Prebiotics May Improve Glycemic Control in Children With Type 1 Diabetes
Prebiotic supplementation may serve as an inexpensive and low-risk treatment addition to improve glycemic control in patients with type 1 diabetes.
Type 1 Diabetes
Additional Positive Phase 3 Data Announced for Ready-to-Use Glucagon Autoinjector
If approved, it would be the first room temperature stable liquid glucagon in an autoinjector formulation.
Full Rotavirus Vaccination Linked to Lower Risk for T1D in Children
Completion of full rotavirus vaccination appears to be associated with a reduction in the risk of type 1 diabetes in children.
Favorable Glycemic Control With Omnipod Insulin Management System Across Age Groups
Both pediatric and adult patients with type 1 diabetes had favorable outcomes for glycemic control with use of the Omnipod® Insulin Management System.
Dasiglucagon Is a Promising Treatment Option for Severe Hypoglycemia
Dasiglucagon was found to be an effective and safe treatment option for severe hypoglycemia in type 1 diabetes.
Predictors of Complication Screening Uptake in Type 1 Diabetes
Patients who attended complication screenings paid more visits to diabetes clinics within the first 2 years after diagnosis, had higher median lifetime HbA1c, and had less socioeconomic disadvantage.
Closed-Loop Insulin Delivery May Reduce Glycemic Variability Across the Menstrual Cycle
Closed-loop insulin delivery may mitigate potential changes in glycemic control throughout the menstrual cycle.
Teplizumab May Prevent Type 1 Diabetes Development in High-Risk Individuals
In people at high risk of developing type 1 diabetes (T1D), teplizumab may delay or prevent disease progression.
Omnipod Hybrid Closed-Loop System Safe for Children With Type 1 Diabetes
The Omnipod HCL system was safe and performed well in children aged 2 to 6 years with type 1 diabetes.
Lower Insulin Demand Associated With Gluten-Free Diet in Recent-Onset T1D
A gluten-free diet was associated with lower insulin demand and HbA1c in T1D.
Next post in ADA 79th Scientific Sessions 2019
